224 related articles for article (PubMed ID: 27109038)
1. Nucleoside-2',3'/3',5'-bis(thio)phosphate antioxidants are also capable of disassembly of amyloid beta42-Zn(ii)/Cu(ii) aggregates via Zn(ii)/Cu(ii)-chelation.
Hevroni BL; Major DT; Dixit M; Mhashal AR; Das S; Fischer B
Org Biomol Chem; 2016 May; 14(20):4640-53. PubMed ID: 27109038
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
Amir A; Shmuel E; Zagalsky R; Sayer AH; Nadel Y; Fischer B
Dalton Trans; 2012 Jul; 41(28):8539-49. PubMed ID: 22652964
[TBL] [Abstract][Full Text] [Related]
3. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside-2',3'/3',5'-bis(thio)phosphate analogues are promising antioxidants acting mainly via Cu+/Fe2+ ion chelation.
Hevroni BL; Sayer AH; Blum E; Fischer B
Inorg Chem; 2014 Feb; 53(3):1594-605. PubMed ID: 24410662
[TBL] [Abstract][Full Text] [Related]
5. Modified EDTA selectively recognized Cu
Chang R; Chen X; Yu H; Tan G; Wen H; Huang J; Hao Z
J Inorg Biochem; 2020 Feb; 203():110929. PubMed ID: 31786439
[TBL] [Abstract][Full Text] [Related]
6. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
7. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometric Zn
Zhang T; Pauly T; Nagel-Steger L
Int J Biol Macromol; 2018 Jul; 113():631-639. PubMed ID: 29476859
[TBL] [Abstract][Full Text] [Related]
9. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
10. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
12. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
13. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
14. Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides.
Liu L; Xia N
Biochem Biophys Res Commun; 2012 Jan; 417(1):153-6. PubMed ID: 22138653
[TBL] [Abstract][Full Text] [Related]
15. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.
Miura T; Suzuki K; Kohata N; Takeuchi H
Biochemistry; 2000 Jun; 39(23):7024-31. PubMed ID: 10841784
[TBL] [Abstract][Full Text] [Related]
16. The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.
Sharma AK; Pavlova ST; Kim J; Kim J; Mirica LM
Metallomics; 2013 Nov; 5(11):1529-36. PubMed ID: 23995980
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cu(II) Binding on Structures and Dynamics of Aβ
Huy PD; Vuong QV; La Penna G; Faller P; Li MS
ACS Chem Neurosci; 2016 Oct; 7(10):1348-1363. PubMed ID: 27454036
[TBL] [Abstract][Full Text] [Related]
18. The chelation targeting metal-Aβ40 aggregates may lead to formation of Aβ40 oligomers.
Zhang Y; Chen LY; Yin WX; Yin J; Zhang SB; Liu CL
Dalton Trans; 2011 May; 40(18):4830-3. PubMed ID: 21437337
[TBL] [Abstract][Full Text] [Related]
19. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
20. Zinc binding promotes greater hydrophobicity in Alzheimer's Aβ42 peptide than copper binding: Molecular dynamics and solvation thermodynamics studies.
Boopathi S; Dinh Quoc Huy P; Gonzalez W; Theodorakis PE; Li MS
Proteins; 2020 Oct; 88(10):1285-1302. PubMed ID: 32419254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
